Trials / Completed
CompletedNCT02380274
Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)
A Prospective Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC) in the United States
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,030 (actual)
- Sponsor
- Astellas Pharma Global Development, Inc. · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to describe patterns of care in CRPC patients, as well as health-related quality of life (HRQoL) outcomes associated with CRPC and its management. This study will also describe factors influencing treatment decisions including reason(s) for treatment choices and triggers for treatment changes for CRPC as well as describe clinical outcomes based on patient characteristics.
Conditions
Timeline
- Start date
- 2015-03-27
- Primary completion
- 2021-01-14
- Completion
- 2021-01-14
- First posted
- 2015-03-05
- Last updated
- 2024-11-20
Locations
148 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02380274. Inclusion in this directory is not an endorsement.